|

6 April 2010
Almus Launches Five New Niche Lines
Almus Pharmaceuticals announces the addition of five new key products to the Almus® range of generic medicines, taking the range to over 250 lines in total. The introduction of Hydrocortisone 10mg and 20mg, Dexamethasone 2mg (50 and 100 pack) and Clonidine Hydrochloride 25mcg further ensure the range has the appropriate balance of important niche lines as well as the top generics required in the dispensary.
Almus Pharmaceuticals leads the way in product packaging, focused on improved selection, accuracy in dispensing and safety for both the pharmacist and patients. Clear product differentiation is achieved through colour contrasts and the life-like pill on pack.
“I am delighted with these significant new additions to the Almus® product portfolio. All five new lines, the hydrocortisone in particular, demonstrate our ongoing commitment to strengthening our range in order to meet pharmacy needs. We will continue to build the Almus® product portfolio in the coming months and to lead the generics market with a superior patient safe pack design,” said Tony Foreman, CEO, Almus Pharmaceuticals.
For more information on the full range of Almus® generic medicines, please contact:
Almus® Sales Tel: 0800 032 0579 Email: almus.sales@almus.co.uk
Medical Information Tel: 0800 917 7983 Email: medinfo@almus.co.uk
For more information please contact:
Sanam Conway, Communications, Almus Pharmaceuticals, sanam.conway@alliance-boots.com, 01932 871564

|